Detalhe da pesquisa
1.
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts.
HIV Med;
25(4): 440-453, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38148567